Global Health Impacts of Nanotechnology Law: A Tool for Stakeholder Engagement /
General Material Designation
[Book]
First Statement of Responsibility
Ilise L Feitshans.
EDITION STATEMENT
Edition Statement
First edition.
.PUBLICATION, DISTRIBUTION, ETC
Name of Publisher, Distributor, etc.
Pan Stanford Publishing,
Date of Publication, Distribution, etc.
2018.
PHYSICAL DESCRIPTION
Specific Material Designation and Extent of Item
1 online resource :
Other Physical Details
text file, PDF
INTERNAL BIBLIOGRAPHIES/INDEXES NOTE
Text of Note
Includes bibliographical references and index.
CONTENTS NOTE
Text of Note
Cover; Half Title; Title; Copyright; Dedication; Contents; Books by the Same Author; Foreword; Preface; Introduction; Chapter 1. Big Questions about Defining Little Nanoparticles; 1.1 How Can Benefits of Nanotechnology Be Realized While Minimizing Risk?; 1.1.1 Simple Applications of Nanotechnology to Daily life; 1.1.2 An Illusion of Consensus: The "Nano" That "Everybody" Knows; 1.1.2.1 Are all of these nanoproducts made of pure nanotechnology that must be regulated?; 1.1.3 Labels: How Big Is Nano, How Small Is NOT Nano?
Text of Note
1.1.4 Capturing Discovery: The Limits of Lists and Numbers as Regulatory Criteria1.2 What Is Nanotechnology?; 1.2.1 Sample Legal Definitions; 1.2.1.1 Example 1: EU NanoReg2; 1.2.1.2 Example 2: EU Commission Recommendation; 1.2.1.3 Example 3: US FDA Definitions for the Purpose of "Guidance for Industry"; 1.2.1.4 Example 4: US TSCA of 2016; 1.3 Invitation to Discovery: The Way Forward with Nanotechnology; Chapter 2. Lessons Learned from the Legend of Asbestos; 2.1 The Legend of Asbestos That Haunts Nanotechnology Law; 2.1.1 Policy Dilemma: No Substitute Works as Good or Harms as Bad as Asbestos.
Text of Note
2.1.2 The Case That Never Ends: Key Asbestos Litigation Including "Cancerphobia"2.1.3 Law of Significant Risk Limiting Dangerous Exposures; 2.2 Lessons Learned from Asbestos; 2.2.1 The Road Not Taken for Asbestos Regulation; 2.2.2 Components of International Regulation of Asbestos Exposure; 2.2.2.1 Medical surveillance; 2.2.2.2 Due diligence; 2.2.2.3 Cost of medical surveillance; 2.2.2.4 Information provided as the right to know, including the GHS; 2.3 Nanotechnology Revolutionizing Risk Communication; 2.3.1 Due Diligence Is Your Best Friend; 2.3.2 Candor, Not Secrecy.
Text of Note
2.3.3 The Question Is Knowledge and Consent, Not the Magnitude of RiskChapter 3. Global Health Impacts: Nanotechnology Fighting Cancer and Disability; 3.1 Revolutionary Promises of Nanomedicine; 3.1.1 Nano World Cancer Day; 3.1.2 Benefits to Patients: New Bones, New Teeth, and New Organs; 3.1.3 New Technologies for HIV-Positive Communities Living with AIDS; 3.1.4 The Fair Share in Posterity for All: Assisted Reproductive Technologies Enabling LGBT Families; 3.2 Global Health Impacts: Improved Quality of Life for Children; 3.2.1 UN International Convention on the Rights of the Child.
Text of Note
3.2.2 Potential Consumer Exposures among Children3.3 Beauty Babies and Dieting: The Impact of Nanotechnology on Women's Health; 3.3.1 Reducing the Global Disease Burden of Maternal Mortality; 3.3.2 International Convention on the Elimination of All Forms of Discrimination against Women: Friend or Foe of Pregnant Women?; 3.4 New Promise for Aging Populations; 3.4.1 A "Revolving Door" for Health Care of the Aging; 3.4.2 Ageless Reproductive Health; Chapter 4. Integrating Nanotechnology into International Laws Protecting Health.
0
8
8
8
8
SUMMARY OR ABSTRACT
Text of Note
"Small things add up: trillions of dollars of products applying nanotechnology have been marketed to consumers promising new medicines, strong packaging to protect goods from contamination, stronger eyelash mascara and long-lasting lipstick, construction materials for housing, cheaper energy, and new drugsto fight cancer. Nanotechnology applications to consumer productsrepresent a huge slice of daily economic life, heralding a revolutionary age for science and technology. How can the benefits of nanotechnology be realized while protecting public health? Global Health Impacts of Nanotechnology Law: A Tool for Stakeholder Engagement fills a major void in legal, scientific policy discourse about nanotechnology for people who are curious about nanoscience, bioethics, and law. The pioneering, plain-language textof Dr. Ilise L. Feitshans, international health law scholar and former international civil servant, enables readers to move comfortably across disciplines and explorehow nanotechnology can reshape both commerce and public health to improve daily life worldwide."--Provided by publisher.